We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$37.3M
Cap. Flow
+$32.9M
Cap. Flow %
18.51%
Top 10 Hldgs %
70.47%
Holding
20
New
2
Increased
11
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
THOR
THORATEC CORPORATION
THOR
+$9.57M
2
GILD icon
Gilead Sciences
GILD
+$9.22M
3
MGLN
Magellan Health Services, Inc.
MGLN
+$5.98M
4
AIQ
Alliance Healthcare Services
AIQ
+$3.49M
5
CRL icon
Charles River Laboratories
CRL
+$3.46M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$5.49M
2
MDT icon
Medtronic
MDT
+$1.72M
3
AORT icon
Artivion
AORT
+$536K
4
CEMI
Chembio diagnostics, Inc.
CEMI
+$288K
5
ICCC icon
ImmuCell
ICCC
+$10.4K

Sector Composition

Rank Sector Weight
1 Healthcare 76.19%
2 Financials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
1
Elevance Health
ELV
$81.5B
$15.7M 8.83%
145,800
+32,000
+28% +$3.3M
THOR
2
DELISTED
THORATEC CORPORATION
THOR
$15.4M 8.64%
440,366
+287,000
+187% +$9.57M
MGLN
3
DELISTED
Magellan Health Services, Inc.
MGLN
$15.1M 8.49%
242,192
+101,817
+73% +$5.98M
CRL icon
4
Charles River Laboratories
CRL
$11.3B
$14.9M 8.38%
278,013
+63,000
+29% +$3.46M
AIQ
5
DELISTED
Alliance Healthcare Services
AIQ
$13.2M 7.45%
490,378
+118,102
+32% +$3.49M
AET
6
DELISTED
Aetna Inc
AET
$10.7M 6%
131,400
+20,500
+18% +$1.55M
LPNT
7
DELISTED
LifePoint Health, Inc.
LPNT
$10.3M 5.81%
166,100
+9,400
+6% +$551K
MDT icon
8
Medtronic
MDT
$112B
$10.2M 5.74%
159,900
-28,300
-15% -$1.72M
HRC
9
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.93M 5.59%
239,200
+17,000
+8% +$661K
GILD icon
10
Gilead Sciences
GILD
$165B
$9.82M 5.53%
+118,500
New +$9.22M
CFN
11
DELISTED
CAREFUSION CORPORATION
CFN
$9.74M 5.48%
219,600
+10,000
+5% +$414K
CAH icon
12
Cardinal Health
CAH
$53.7B
$9.3M 5.24%
135,700
+17,000
+14% +$1.16M
HOLX
13
DELISTED
Hologic
HOLX
$8.16M 4.6%
321,920
-235,000
-42% -$5.49M
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
$7.45M 4.2%
107,500
– –
SKH
15
DELISTED
SKILLED HEALTHCARE GROUP, INC. CLASS A COM STK
SKH
$7M 3.94%
1,112,885
+197,520
+22% +$1.15M
GTS
16
DELISTED
Triple-S Management Corporation
GTS
$6.36M 3.58%
372,801
– –
AORT icon
17
Artivion
AORT
$1.34B
$3.7M 2.08%
413,364
-58,239
-12% -$536K
NOTV
18
DELISTED
Inotiv
NOTV
$392K 0.22%
+155,097
New +$413K
ICCC icon
19
ImmuCell
ICCC
$99.6M
$345K 0.19%
78,477
-2,469
-3% -$10.4K
CEMI
20
DELISTED
Chembio diagnostics, Inc.
CEMI
– –
-83,372
Closed -$288K

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
AWA
Acumen Wealth Advisors Chattanooga, Tennessee $372M AUM
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
SC
Saybrook Capital Winston Salem, North Carolina $371M AUM 13.23% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

HealthInvest Partners's Q2 2014 Portfolio in Review

As of Q2 2014, HealthInvest Partners held 20 positions worth $178M, up 27% from $140M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

HealthInvest Partners deployed $32.9M of net new capital in Q2 2014, opening 2 new positions and adding to 11 existing holdings. Its largest new stake was Gilead Sciences: 118,500 shares worth $9.82M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 80% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Hologic, an estimated $5.49M trimmed.

  • HealthInvest Partners's largest Q2 2014 buy was Gilead Sciences: 118,500 shares worth $9.82M.
  • HealthInvest Partners added most to THORATEC CORPORATION in Q2 2014, an estimated $9.57M increase.
  • HealthInvest Partners's biggest Q2 2014 reduction was Hologic, cutting an estimated $5.49M.
  • HealthInvest Partners fully exited Chembio diagnostics, Inc. in Q2 2014, selling an estimated $288K.
  • HealthInvest Partners's ten largest holdings make up 70% of its $178M portfolio in Q2 2014.
  • HealthInvest Partners opened 2 new positions and closed 1 in Q2 2014.
  • HealthInvest Partners's portfolio value rose 27% quarter-over-quarter to $178M.

Based on HealthInvest Partners's 13F filing for Q2 2014, filed 17 Jul 2014.